Related Experiment Video
Updated: Aug 13, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
One-year survival and prognostic factors for survival among stroke patients: The PROVE-stroke study
Mahshid Givi1, Negin Badihian2, Marzieh Taheri3
1Nursing and Midwifery Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Stroke survival rates in Iran show that 72.1% of patients lived one year post-stroke. Key predictors included age, diabetes, prior stroke, and hospital complications like hemorrhage and sepsis.
Area of Science:
- Neurology
- Public Health
- Epidemiology
Background:
- Stroke incidence and outcomes vary globally, with limited data from the Middle East.
- Understanding regional stroke patterns is crucial for targeted public health interventions.
Purpose of the Study:
- To determine 1-year survival rates among stroke patients in Central Iran.
- To identify prognostic factors influencing stroke survival in this specific population.
Main Methods:
- An observational analytical study using the PROVE-Stroke database.
- Reviewed records of 1703 patients admitted for stroke in Isfahan, Iran, between 2015-2016.
- Collected data on demographics, clinical details, comorbidities, and 1-year survival status.
Main Results:
- Out of 1345 patients, 970 (72.1%) survived one year, with a mean survival time of 277.33 days.
- Ischemic stroke (84.8%) was more common than hemorrhagic stroke (15.0%).
- Significant predictors of mortality included advanced age, diabetes, history of stroke/TIA, warfarin use, hospital-acquired hemorrhage, sepsis, hydrocephalus, and a modified Rankin Scale score of ≥3 at discharge.
Conclusions:
- Identified both unmodifiable (age, diabetes, prior stroke, mRS) and modifiable (hospital complications) predictors of 1-year stroke survival.
- Highlights the importance of managing hospital-acquired complications to reduce stroke mortality.
Background:
Survival and prognostic factors following stroke occurrence differ between world regions. Studies investigating stroke features in the Middle-east region are scarce. We aimed to investigate 1-year survival and related prognostic factors of stroke patients in Central Iran.
Materials And Methods:
It is an observational analytical study conducted on patients registered in the Persian Registry of Cardiovascular Disease-Stroke (PROVE-Stroke) database. Records of 1703 patients admitted during 2015-2016 with the primary diagnosis of stroke in all hospitals of Isfahan, Iran were reviewed. Information regarding sociodemographic characteristics, clinical presentations, medications, and comorbidities were recorded. The living status of patients after 1 year from stroke was considered as 1-year survival.
Results:
Among 1345 patients with the final diagnosis of stroke, 970 (72.1%) were alive at the 1 year follow-up and the mean survival time based on Kaplan-Meier procedure was estimated 277.33 days. The hemorrhagic and ischemic types of stroke were reported in 201 (15.0%) and 1141 (84.8%) patients, respectively. Age (hazard ratio [HR] = 1.07, 95% confidence interval [CI] = 1.05-1.09), diabetes (HR = 1.49, 95% CI = 1.07-2.06), history of stroke or transient ischemic attack (HR = 1.81, 95% CI = 1.30-2.52), history of warfarin usage (HR = 1.73, 95% CI = 1.11-2.71), hospital complications of hemorrhage (HR = 3.89, 95% CI = 2.07-7.31), sepsis (HR = 1.78, 95% CI = 1.18-2.68), and hydrocephalus (HR = 3.43, 95% CI = 1.34-8.79), and modified Rankin Scale (mRS) ≥3 at the time of hospital dicharge (HR = 1.98, 95% CI = 1.27-3.07), were predictors of 1-year survival.
Conclusion:
Predictors of 1-year survival can be categorized into unchangeable ones, such as age, diabetes, previous stroke, and mRS. The changeable factors, such as hospital complications of infection and hemorrhage, guide physicians to pay greater attention to reduce the risk of mortality following stroke.
Related Concept Videos
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cancer Survival Analysis
Atherosclerosis IV: Nursing Management
Assumptions of Survival Analysis

